Long-term outcomes of the INO-VATE ALL study in patients with relapsed/refractory acute lymphoblastic leukemia: Response rates and survival outcomes by bone marrow blast percentage Stelljes, M., Marks, D., DeAngelo, D. J., Liedtke, M., Stock, W., Goekbuget, N., O'Brien, S., Jabbour, E., Merchant, A., Wang, T., Vandendries, E., Neuhof, A., Advani, A., Kantarjian, H. KARGER. 2018: 24–25

View details for Web of Science ID 000446816500063